Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.
Journal Information
Journal Title: Ther Adv Urol
Detailed journal information not available.
Publication Details
Subject Category: Urology & Nephrology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The authors declare that there is no conflict of interest."
"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by an inter-regional academic grant from the French Cancer Research Hospital Program (PHRCI-17-081) and by the French League Against Cancer. The trial was promoted by the Comprehensive Cancer Centre François Baclesse, Caen, France. The funding agencies were not involved in the design and conduct of the study, nor the collection, management, analysis, interpretation of data, the writing of the manuscript, and the decision to submit the manuscript for publication."
"Trial registration: NCT03652493, EudraCT ID number 2017-004764-35."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025